104 related articles for article (PubMed ID: 18057258)
1. Transgene expression facilitated by the v-src splice acceptor can impair replication kinetics and lead to genomic instability of Rous sarcoma virus-based vectors.
Portsmouth D; Deitermann D; Salmons B; Günzburg WH; Renner M
J Virol; 2008 Feb; 82(3):1610-4. PubMed ID: 18057258
[TBL] [Abstract][Full Text] [Related]
2. Effects of viral strain, transgene position, and target cell type on replication kinetics, genomic stability, and transgene expression of replication-competent murine leukemia virus-based vectors.
Paar M; Schwab S; Rosenfellner D; Salmons B; Günzburg WH; Renner M; Portsmouth D
J Virol; 2007 Jul; 81(13):6973-83. PubMed ID: 17442710
[TBL] [Abstract][Full Text] [Related]
3. Construction of retroviral vectors with enhanced efficiency of transgene expression.
Hahm SH; Yi Y; Lee DK; Noh MJ; Yun L; Hwang S; Lee KH
J Virol Methods; 2004 Nov; 121(2):127-36. PubMed ID: 15381349
[TBL] [Abstract][Full Text] [Related]
4. Promoters influence the kinetics of transgene expression following adenovector gene delivery.
Chen P; Tian J; Kovesdi I; Bruder JT
J Gene Med; 2008 Feb; 10(2):123-31. PubMed ID: 18064718
[TBL] [Abstract][Full Text] [Related]
5. Human immunodeficiency virus type 2 lentiviral vectors: packaging signal and splice donor in expression and encapsidation.
D'Costa J; Brown HM; Kundra P; Davis-Warren A; Arya SK
J Gen Virol; 2001 Feb; 82(Pt 2):425-434. PubMed ID: 11161282
[TBL] [Abstract][Full Text] [Related]
6. Mutagenesis of the region between env and src of the SR-A strain of Rous sarcoma virus for the purpose of constructing helper-independent vectors.
Hughes S; Kosik E
Virology; 1984 Jul; 136(1):89-99. PubMed ID: 6330999
[TBL] [Abstract][Full Text] [Related]
7. A uniquely stable replication-competent retrovirus vector achieves efficient gene delivery in vitro and in solid tumors.
Logg CR; Tai CK; Logg A; Anderson WF; Kasahara N
Hum Gene Ther; 2001 May; 12(8):921-32. PubMed ID: 11387057
[TBL] [Abstract][Full Text] [Related]
8. Rous Sarcoma Virus Genomic RNA Dimerization Capability In Vitro Is Not a Prerequisite for Viral Infectivity.
Liu S; Kaddis Maldonado R; Rye-McCurdy T; Binkley C; Bah A; Chen EC; Rice BL; Parent LJ; Musier-Forsyth K
Viruses; 2020 May; 12(5):. PubMed ID: 32455905
[TBL] [Abstract][Full Text] [Related]
9. A suboptimal src 3' splice site is necessary for efficient replication of Rous sarcoma virus.
Zhang L; Stoltzfus CM
Virology; 1995 Feb; 206(2):1099-107. PubMed ID: 7856084
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a semi-replicative gene delivery system allowing propagation of complementary defective retroviral vectors.
Trajcevski S; Solly SK; Frisén C; Trenado A; Cosset FL; Klatzmann D
J Gene Med; 2005 Mar; 7(3):276-87. PubMed ID: 15515136
[TBL] [Abstract][Full Text] [Related]
11. Effects of the gag region on genome stability: avian retroviral vectors that contain sequences from the Bryan strain of Rous sarcoma virus.
Federspiel MJ; Hughes SH
Virology; 1994 Sep; 203(2):211-20. PubMed ID: 8053145
[TBL] [Abstract][Full Text] [Related]
12. Influence of vector design and host cell on the mechanism of recombination and emergence of mutant subpopulations of replicating retroviral vectors.
Paar M; Klein D; Salmons B; Günzburg WH; Renner M; Portsmouth D
BMC Mol Biol; 2009 Feb; 10():8. PubMed ID: 19203366
[TBL] [Abstract][Full Text] [Related]
13. Rous sarcoma virus translation revisited: characterization of an internal ribosome entry segment in the 5' leader of the genomic RNA.
Deffaud C; Darlix JL
J Virol; 2000 Dec; 74(24):11581-8. PubMed ID: 11090156
[TBL] [Abstract][Full Text] [Related]
14. The production of viral vectors designed to express large and difficult to express transgenes within neurons.
Holehonnur R; Lella SK; Ho A; Luong JA; Ploski JE
Mol Brain; 2015 Feb; 8():12. PubMed ID: 25887710
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the E3 and L3 regions for arming oncolytic adenoviruses to achieve a high level of tumor-specific transgene expression.
Robinson M; Ge Y; Ko D; Yendluri S; Laflamme G; Hawkins L; Jooss K
Cancer Gene Ther; 2008 Jan; 15(1):9-17. PubMed ID: 17853920
[TBL] [Abstract][Full Text] [Related]
16. Serine/arginine-rich proteins contribute to negative regulator of splicing element-stimulated polyadenylation in rous sarcoma virus.
Maciolek NL; McNally MT
J Virol; 2007 Oct; 81(20):11208-17. PubMed ID: 17670832
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety analyses of a recombinant human immunodeficiency virus type 1 derived vector system.
Chang LJ; Urlacher V; Iwakuma T; Cui Y; Zucali J
Gene Ther; 1999 May; 6(5):715-28. PubMed ID: 10505094
[TBL] [Abstract][Full Text] [Related]
18. Vincristine-resistant human laryngeal carcinoma cells demonstrate increased Rous sarcoma virus promoter activity.
Majhen D; Brozovic A; Buger T; Gabrilovac J; Osmak M; Ambriović-Ristov A
Life Sci; 2010 Oct; 87(15-16):468-74. PubMed ID: 20837033
[TBL] [Abstract][Full Text] [Related]
19. The encephalomyocarditis virus internal ribosome entry site allows efficient coexpression of two genes from a recombinant provirus in cultured cells and in embryos.
Ghattas IR; Sanes JR; Majors JE
Mol Cell Biol; 1991 Dec; 11(12):5848-59. PubMed ID: 1658618
[TBL] [Abstract][Full Text] [Related]
20. Expression of Rous sarcoma virus-derived retroviral vectors in the avian blastoderm: potential as stable genetic markers.
Reddy ST; Stoker AW; Bissell MJ
Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10505-9. PubMed ID: 1660139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
